🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase I/II, double-blind, placebo-controlled trial investig...
Status
Completed
Location
XBiotech Investigative Site
Start Date
2015-05
Trial ID
NCT02357966
Treatments Being Tested
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Completed
Location
ICON Early Development Services
Start Date
2023-01-17
Trial ID
NCT05723692
The purpose of this study is to establish the safety, tolerability, and pha...
Status
Completed
Location
Uniformed Services University of the HEalth Sciences
Start Date
2006-06-12
Trial ID
NCT00292942
Treatments Being Tested
To evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenici...
Status
Completed
Location
Seoul National University Hospital
Start Date
2018-02-07
Trial ID
NCT03446053
Treatments Being Tested
A phase 1, randomized, placebo-controlled, double-blind, dose escalation tr...
Status
Completed
Location
Hôpital Henri Mondor
Start Date
2020-02-10
Trial ID
NCT04360434
The purpose of this study was assess the safety and efficacy of leronlimab ...
Status
Completed
Location
Advanced Cardiovascular, LLC
Start Date
2020-04-16
Trial ID
NCT04347239
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of 4...
Status
Not Yet Recruiting
Location
Soweto HVTN CRS
Start Date
2026-07-13
Trial ID
NCT06613789
Treatments Being Tested
The purpose of this study is to determine safety and immunogenicity (abilit...
Status
Completed
Location
SGS Biopharma
Start Date
2003-12
Trial ID
NCT00482027
Treatments Being Tested
This is a randomized, placebo-controlled interventional study. The main pur...
Status
Completed
Location
Pharmaron
Start Date
2022-08-15
Trial ID
NCT05525546
The Objectives of this study is to evaluate the safety, pharmacokinetics an...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-08-06
Trial ID
NCT01855048
Treatments Being Tested